Title: Human hepatic metabolism of the anti-osteoporosis drug eldecalcitol involves sterol C4-methyl oxidase.
Journal: Pharmacology research & perspectives20150301
Title: Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
Journal: Bone20131101
Title: Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment levels.
Journal: Current medical research and opinion20120901
Title: Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies.
Journal: Archives of biochemistry and biophysics20120701
Title: [New approved drugs for osteoporosis in Japan].
Journal: Clinical calcium20120601
Title: Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
Journal: Bone20120501
Title: Eldecalcitol for the treatment of osteoporosis.
Journal: Drugs of today (Barcelona, Spain : 1998)20120301
Title: Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research20120201
Title: Process development for the practical production of eldecalcitol by linear, convergent and biomimetic syntheses.
Journal: Anticancer research20120101
Title: The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism.
Journal: Calcified tissue international20111101
Title: [Frontiers in vitamin D; basic research and clinical application. Exploratory research, biological characteristic and pharmacokinetics of eldecalcitol, a new active vitamin D derivative].
Journal: Clinical calcium20111101
Title: [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
Journal: Clinical calcium20111101
Title: [Frontiers in vitamin D; Basic research and clinical application. The effects of eldecalcitol on bone mineral density and fracture prevention--Post hoc analysis].
Journal: Clinical calcium20111101
Title: [Frontiers in vitamin D; Basic research and clinical application. Effect of eldecalcitol on bone structure].
Journal: Clinical calcium20111101
Title: A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.
Journal: Bone20111001
Title: Eldecalcitol: a review of its use in the treatment of osteoporosis.
Journal: Drugs20110910
Title: Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
Journal: Bone20110901
Title: [Diagnostic imaging of treatment in osteoporosis; new active vitamin D].
Journal: Clinical calcium20110701
Title: Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism.
Journal: Journal of cellular biochemistry20110501
Title: [Eldecalcitol (ED-71)].
Journal: Clinical calcium20110101
Title: [ASBMR 2010 report. Meeting report on the ASBMR. Obstacles in medicine for osteoporosis].
Journal: Clinical calcium20110101
Title: Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer.
Journal: Structure (London, England : 1993)20101013
Title: Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
Journal: The Journal of steroid biochemistry and molecular biology20100701
Title: Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71].
Journal: The Journal of steroid biochemistry and molecular biology20100701
Title: Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo.
Journal: The Journal of steroid biochemistry and molecular biology20100701
Title: D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.
Journal: Mini reviews in medicinal chemistry20091001
Title: Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
Journal: Anticancer research20090901
Title: [New bone density conservation agents for osteoporosis under research and development: ED-71].
Journal: Nihon rinsho. Japanese journal of clinical medicine20071128
Title: Synthesis and biological evaluation of a 3-positon epimer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
Journal: The Journal of steroid biochemistry and molecular biology20070301
Title: ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects.
Journal: The Journal of steroid biochemistry and molecular biology20070301
Title: ED-71, a novel vitamin D analog, promotes bone formation and angiogenesis and inhibits bone resorption after bone marrow ablation.
Journal: Bone20070201
Title: 1Alpha,25-dihydroxy-2beta(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora.
Journal: Bone20070101
Title: [Therapeutic agents for disorders of bone and calcium metabolism: ED-71].
Journal: Clinical calcium20070101
Title: Synthesis of putative metabolites of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (ED-71).
Journal: Steroids20060701
Title: [Progress in research on vitamin D analogs].
Journal: Clinical calcium20060701
Title: [Vitamin-D analogues for osteoporosis].
Journal: Clinical calcium20060701
Title: [New horizons of ED-71 (vitamin D analog)].
Journal: Clinical calcium20060101
Title: The determination of 2beta-(3-hydroxypropoxy)-1alpha,25-dihydroxy vitamin D3 (ED-71) in human serum by high-performance liquid chromatography-electrospray tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20050905
Title: A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
Journal: The Journal of clinical endocrinology and metabolism20050901
Title: [Vitamin D and its derivatives as anti-osteoporotic drugs].
Journal: Clinical calcium20050401
Title: [Influencing factors on distraction osteogenesis].
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology20040701
Title: [The trend in the development of the active vitamin D3 and its analogues].
Journal: Nihon rinsho. Japanese journal of clinical medicine20040501
Title: ED-71 Chugai.
Journal: Current opinion in investigational drugs (London, England : 2000)20040401
Title: [ED-71].
Journal: Nihon rinsho. Japanese journal of clinical medicine20040201
Title: A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
Journal: Journal of cellular biochemistry20030201
Title: Rationale for active vitamin D and analogs in the treatment of osteoporosis.
Journal: Journal of cellular biochemistry20030201
Title: [Osteoporosis].
Journal: Ryumachi. [Rheumatism]20021201
Title: ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
Journal: Bone20020401
Title: [Drugs in development for the treatment of osteoporosis: Active vitamin D analog(ED-71)].
Journal: Nihon rinsho. Japanese journal of clinical medicine20020301
Title: History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71).
Journal: Steroids20010101
Title: Synthesis and biological characterization of 1alpha,24,25-trihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (24-hydroxylated ED-71).
Journal: Steroids20010101
Title: Synthetic studies of vitamin D analogues. XIV. Synthesis and calcium regulating activity of vitamin D3 analogues bearing a hydroxyalkoxy group at the 2 beta-position.
Journal: Chemical & pharmaceutical bulletin19930601
Title: Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
Journal: Bone19930101
